NRX Pharmaceuticals, Inc. Warrant (NRXPW) Total Assets by Year
NRX Pharmaceuticals, Inc. Warrant closed fiscal year 2025 with $13.0M in total assets, $28.9M in total liabilities and -$15.9M in shareholder equity. This represents an increase of 254.9% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters NRX Pharmaceuticals, Inc. Warrant has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NRXPW Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.0M+254.9% | $3.7M-50.1% | $7.3M-71.7% | $25.8M-21.1% | $32.7M+1012.8% | $2.9M-90.8% | $32.1M-54.7% | $70.8M |
| Total Liabilities | $28.9M+7.5% | $26.9M+41.1% | $19.0M+3.5% | $18.4M+54.4% | $11.9M-74.5% | $46.7M+26.5% | $36.9M-43.9% | $65.8M |
| Total Equity | -$15.9M+31.4% | -$23.2M-97.9% | -$11.7M-258.4% | $7.4M-64.4% | $20.8M+147.5% | -$43.8M-803.7% | -$4.8M-196.9% | $5.0M |
NRXPW Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.9M+56.8% | $13.0M+254.9% | $15.0M+236.1% | $4.8M-8.1% | $7.6M+100.4% | $3.7M-50.1% | $4.5M-66.0% | $5.3M-73.4% | $3.8M-82.6% | $7.3M-71.7% | $13.1M-47.2% | $19.8M-38.9% |
| Total Liabilities | $25.7M-21.5% | $28.9M+7.5% | $40.8M+75.0% | $40.5M+71.0% | $32.8M+73.7% | $26.9M+41.1% | $23.3M+20.5% | $23.7M+4.6% | $18.9M-14.5% | $19.0M+3.5% | $19.3M+140.3% | $22.6M+219.4% |
| Total Equity | -$13.8M+45.1% | -$15.9M+31.4% | -$25.8M-36.8% | -$35.6M-93.7% | -$25.2M-67.0% | -$23.2M-97.9% | -$18.8M-202.8% | -$18.4M-555.0% | -$15.1M-5206.0% | -$11.7M-258.4% | -$6.2M-137.0% | -$2.8M-111.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More NRX Pharmaceuticals, Inc. Warrant financials
Frequently Asked Questions
What was NRX Pharmaceuticals, Inc. Warrant's total assets in fiscal year 2025?
NRX Pharmaceuticals, Inc. Warrant closed fiscal year 2025 with $13.0M in total assets, $28.9M in total liabilities and -$15.9M in shareholder equity.
How fast is NRX Pharmaceuticals, Inc. Warrant's total assets growing?
NRX Pharmaceuticals, Inc. Warrant (NRXPW) total assets rose by 254.9% year over year, from $3.7M to $13.0M in fiscal year 2025.
How has NRX Pharmaceuticals, Inc. Warrant's total assets changed over the years?
Across the 8 fiscal years this page covers, NRX Pharmaceuticals, Inc. Warrant (NRXPW) total assets went from $70.8M in fiscal year 2018 to $13.0M in fiscal year 2025.
What was NRX Pharmaceuticals, Inc. Warrant's total assets in the most recent quarter?
NRX Pharmaceuticals, Inc. Warrant (NRXPW) reported $11.9M in total assets in Q1 2026. This represents an increase of 56.8% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what NRX Pharmaceuticals, Inc. Warrant (NRXPW) reported on that line in every period on record.